Peyton Marshall

Peyton Marshall is the current Chief Executive Officer and President at LeveragePoint. Prior to this, they served as a Strategic Advisor at Foldrx Pharmaceuticals from June 2009 to June 2011. From January 2005 to December 2007, they were the EVP & CFO, Acting CEO at Panacos Pharmaceuticals. Peyton was also the Acting COO at Therasis Inc. from November 2009 to February 2011. From May 2007 to December 2013, they worked as a Consultant at Miscellaneous. Additionally, they served as the Chief Financial Officer at EPIX Pharmaceuticals from January 2002 to December 2005 and The Medicines Company from January 1997 to December 2002. Peyton started their career as the Managing Director, Financing and Risk Management at UBS from January 1995 to December 1997 and Executive Director at Goldman Sachs from July 1986 to January 1995.

Peyton Marshall has a PhD in Economics from the Massachusetts Institute of Technology and an AB in Economics from Davidson College.

Some individuals on their team include Kevin Spaeth - Vice President, Engineering, Chithra Baylis - VP, Finance & Business Administration and Treasurer, and Brian Hannon - VP, Sales.